Literature DB >> 18049722

Retigabine: has the orphan found a home?

Elinor Ben-Menachem.   

Abstract

Year:  2007        PMID： 18049722      PMCID： PMC2096728          DOI： 10.1111/j.1535-7511.2007.00209.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  13 in total

1.  Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo.

Authors:  Gabriela Mora; Ricardo Tapia
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

2.  Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by 4-aminopyridine in rat entorhinal cortex hippocampal slices.

Authors:  V Armand; C Rundfeldt; U Heinemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-01       Impact factor: 3.000

3.  Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices.

Authors:  V Armand; C Rundfeldt; U Heinemann
Journal:  Epilepsia       Date:  2000-01       Impact factor: 5.864

Review 4.  Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs.

Authors:  E C Cooper
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

5.  The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.

Authors:  C Rundfeldt; R Netzer
Journal:  Neurosci Lett       Date:  2000-03-17       Impact factor: 3.046

Review 6.  Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation.

Authors:  J A Cramer; E Ben Menachem; J French
Journal:  Epilepsy Res       Date:  2001-11       Impact factor: 3.045

7.  The anticonvulsant retigabine potently suppresses epileptiform discharges in the low Ca ++ and low Mg++ model in the hippocampal slice preparation.

Authors:  R Dost; C Rundfeldt
Journal:  Epilepsy Res       Date:  2000-01       Impact factor: 3.045

8.  D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures.

Authors:  C Tober; A Rostock; C Rundfeldt; R Bartsch
Journal:  Eur J Pharmacol       Date:  1996-05-15       Impact factor: 4.432

9.  Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.

Authors:  R J Porter; A Partiot; R Sachdeo; V Nohria; W M Alves
Journal:  Neurology       Date:  2007-04-10       Impact factor: 9.910

10.  D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

Authors:  A Rostock; C Tober; C Rundfeldt; R Bartsch; J Engel; E E Polymeropoulos; B Kutscher; W Löscher; D Hönack; H S White; H H Wolf
Journal:  Epilepsy Res       Date:  1996-04       Impact factor: 3.045
View more
  3 in total

1.  Ezogabine: a new angle on potassium gates.

Authors:  Edward Faught
Journal:  Epilepsy Curr       Date:  2011-05       Impact factor: 7.500

2.  The mechanism of abrupt transition between theta and hyper-excitable spiking activity in medial entorhinal cortex layer II stellate cells.

Authors:  Tilman Kispersky; John A White; Horacio G Rotstein
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

3.  Recent and Emerging Anti-seizure Drugs: 2013.

Authors:  William O Tatum
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.